Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...

This revolutionary approach has given hope to patients who previously had limited or no options, particularly those battling ...

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors—a smart fighter that destroys ...

A multi-institutional team led by The University of Osaka developed a chimeric antigen receptor (CAR) T cell-based strategy ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

Industry leaders such as Bristol Myers Squibb are at the forefront of this revolution, driving advancements that can redefine ...

CAR-T cell therapy involves extracting a ... In the meantime, the researchers are also testing the treatment on other types of cancers including acute myeloid leukemia, multiple myeloma, and ...

Now, as a scientist at the University of Pennsylvania, Charly is working to rewrite the future of cancer treatment.

Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

Kohler said the same CAR-T cell therapies have been used for more ... In the meantime, the researchers are also testing the treatment on other types of cancers including acute myeloid leukemia ...

In March 2025, Celgene announced a study is to compare the effectiveness and safety of golcadomide in combination with ...